Clinical Trial Update: Phase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy [Phase 2]

View source ↗

Summary

Phase II umbrella study evaluating multiple novel anti-cancer agents in non-small cell lung cancer patients who progressed on anti-PD-1/PD-L1 therapy; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-10-27